NATO StratCom Features Mauritz Kop as Subject Matter Expert in Workshop Video on Quantum and Cognitive Sovereignty

The NATO Strategic Communications Centre of Excellence engaged Mauritz Kop as a subject-matter expert for its Riga workshop The Integrity of Reality and Cognitive Sovereignty—via a thirty-minute video interview recorded as study material for participants and as input to the Centre's threatcasting work.

A video briefing for Riga

Held in early June 2026, in the week of the Centre's flagship Riga StratCom Dialogue, the workshop examined what happens to shared truth when both conflict and communication are increasingly automated. Kop's recorded interview adds the layer the strategic-communications field is only beginning to map: the quantum layer. His opening line does the analytical work of a whole briefing—the past is not yet stable. The argument extends the case he made when the Hoover Institution invited him to speak on quantum, democracy, and authoritarianism.

Three quantum pressures on the mind's privacy

The interview names three converging pressures on cognitive sovereignty: civic-scale quantum sensing that, in principle, could resolve subsurface and interior spaces from public rights-of-way—what Kop calls the X-Ray City scenario; quantum-enhanced biosensing and brain-computer interfaces that open the inference of mental states; and the temporal instability of the cryptographic record under harvest-now, decrypt-later collection. For the first two, Kop argues for capability protection—prohibition-grade guardrails at the infrastructure layer, not consent forms after deployment.

Why communicators should care about cryptography

An adversary who can retroactively forge or contest the signed record does not need to fabricate convincingly—only to seed doubt at scale. The interview's prescription is precision over speed: the LSI test for every proposed control, standards-first governance, and verifiable allied migration to post-quantum cryptography as the strategic-communications measure rarely recognized as one.

Meer lezen

Quantum Technology, Geopolitics, GovernanceHenry Quentir3 juni 2026Mauritz Kop, National Security, Quantum Governance, Geopolitics, Post-Quantum Cryptography, NATO, NATO StratCom COE, Cognitive Sovereignty, Riga StratCom Dialogue, Threatcasting, Quantum Sensing

A Brief Quantum Medicine Policy Guide: What Regulators Should Consider for Quantum and AI in Precision Medicine

As quantum technology and artificial intelligence move toward precision medicine, regulators face a problem they have not yet built tools for. A Brief Quantum Medicine Policy Guide—published on the Harvard Petrie-Flom Center's Bill of Health blog by Mauritz Kop, Suzan Slijpen, Katie Liu, Jin-Hee Lee, Constanze Albrecht, and I. Glenn Cohen, and cross-posted with the Stanford Center for Responsible Quantum Technology and the European Commission's European AI Alliance—is a concise map of the use cases, the overlapping legal regimes, and what agencies such as the FDA and EMA should consider. It is a companion to the team's longer treatment of how quantum technologies may be integrated into healthcare, and continues the collaboration later reflected in Kop's work consulting Amgen on quantum biomedical discovery.

Quantum use cases in healthcare

The guide sorts second-generation quantum medicine by domain. Quantum computing and simulation could accelerate de novo drug discovery by modeling molecular interactions, speed genome sequencing, and assist protein-folding prediction; quantum sensing could deliver continuous high-precision vital-sign monitoring, precision laser therapy, and earlier retinal diagnostics; post-quantum cryptography and quantum key distribution could secure patient data in line with HIPAA and GDPR. A recurring thread is the semiconducting quantum dot, whose ability to cross the blood-brain barrier opens possibilities in oncology imaging, targeted drug delivery, and neurodegenerative-disease research. Throughout, the authors keep the claims proportionate, marking many applications as early-stage or theoretical.

A fragmented regulatory map

There is no quantum-specific medical-device law in either the EU or the US. European devices fall mainly under the Medical Devices Regulation, with the EU AI Act and data laws in supporting roles, while CE marking is slowed by a shortage of Notified Bodies versed in AI or quantum. US devices may sit within the existing FDA framework—potentially including the Software-as-a-Medical-Device pathway—alongside HIPAA, the FTC, and standards such as ISO 13485. The guide's first practical counsel is for manufacturers to engage agencies early.

What regulators should build next

The guide names four changes: evaluation protocols attuned to quantum behaviors; risk-management frameworks that protect human subjects from quantum unpredictability; clinical-trial guidelines tailored to quantum devices; and interoperability standards. It then proposes a three-part architecture—ex-ante regulatory sandboxes for quantum-AI devices, ex-durante expert subcommittees, and an ex-post registration database—framed by ten guiding principles, from promoting quantum literacy to fostering institutional plasticity in bodies like the FDA and EMA. The throughline is a standards-first, anticipatory posture: prepare the institutions before the technology arrives, and balance innovation against patient safety rather than choosing between them.